PTHLH and Hypercalcemia: Hypercalcemia in cancer results from parathyroid hormone-related protein (PTHrP) secretion or activation of the receptor for nuclear factor-kB ligand, with bone metastases and increased osteoclastic activity accounting for about 20% of instances [231,232].